SCP
CELG

Seizert Capital Partners’s Celgene Corp CELG Stock Holding History

Seizert Capital Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-70,018
Closed -$6.95M – 237
2019
Q3 		$6.95M Sell
70,018
-186,642
-73% -$17.7M 0.35% 58
2019
Q2 		$23.7M Sell
256,660
-25,358
-9% -$2.41M 1.17% 35
2019
Q1 		$26.6M Sell
282,018
-72,484
-20% -$6.34M 1.19% 36
2018
Q4 		$22.7M Buy
354,502
+14,333
+4% +$1.06M 1.03% 46
2018
Q3 		$30.4M Buy
340,169
+62,492
+23% +$5.52M 1.12% 34
2018
Q2 		$24.8M Hold
277,677
– – 0.9% 43
2018
Q1 		$24.8M Buy
277,677
+72,988
+36% +$7.01M 0.9% 43
2017
Q4 		$21.4M Buy
204,689
+119,168
+139% +$13.4M 0.77% 50
2017
Q3 		$12.5M Sell
85,521
-2,847
-3% -$388K 0.46% 56
2017
Q2 		$11.5M Buy
88,368
+5,748
+7% +$704K 0.42% 59
2017
Q1 		$10.3M Buy
82,620
+20,263
+32% +$2.42M 0.37% 63
2016
Q4 		$7.22M Buy
+62,357
New +$6.94M 0.26% 73
2015
Q3 		– Sell
-1,900
Closed -$220K – 216
2015
Q2 		$220K Buy
+1,900
New +$217K 0.01% 202

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Seizert Capital Partners's CELG Position: Q4 2019 in Review

Seizert Capital Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 70,018 shares — an estimated $6.95M sold.

Seizert Capital Partners first reported a position in CELG in Q2 2015 and held it in 13 quarters. The position peaked at $30.4M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Seizert Capital Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Seizert Capital Partners sold 70,018 Celgene Corp shares in Q4 2019, an estimated $6.95M.
  • Seizert Capital Partners first reported a position in Celgene Corp in Q2 2015 and held it in 13 quarters.
  • Seizert Capital Partners's Celgene Corp position peaked at $30.4M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Seizert Capital Partners's 13F filing for Q4 2019, filed 10 Feb 2020.